The Luxembourg BioHealth Cluster aims to strengthen and capitalise on the national strategy developed by Luxembourg’s government to achieve scientific excellence in molecular diagnostics, the cornerstone of personalised medicine.

Its members are R&D companies, public research organisations, laboratories, hospitals and other actors (patients associations, service and capital providers, etc.) whose activities are related to health sciences and technologies.

The main focus of the Cluster is personalised medicine, an area in which Luxembourg has identified niche areas of expertise where the country has strong potential to be competitive at a global level: digital health, neurodegenerative diseases, molecular diagnostics and immune-oncology.

Objectives:

–   reinforcing and capitalising on Luxembourg’s national strategy to achieve scientific excellence in molecular diagnostics

–   enhance Luxembourg’s reputation as a recognised and attractive environment for biomedical research, development, innovation (RDI) and business.

–   support the community, help members find new opportunities for advancement here in Luxembourg and abroad, and work with them to articulate their needs and their challenges at a national level.

Luxembourg BioHealth Cluster

company / private organisation

MEMBERS CATALOGUE

Did you know...

Stay up to date

Latest news

“2016 In Review” IBBL’s Annual Report Goes Digital

18-05-2017

“2016 In Review” looks back into the year 2016 in a refreshing way and highlights IBBL’s key achievements.
Read more

Luxembourg 3rd most attractive city to move to for work

17-05-2017

Using data from its in-house survey team, which continually researches the financial and lifestyle conditions of more than 400 cities around the world, AIRINC, a global research company which current...
Read more

The Collaboration Factory

16-05-2017

After 10 years and €1 billion in investment, the Belval innovation campus has become one of Europe’s foremost centers for technology and biomedical collaborations.    
Read more

Treating cancer with viruses

03-05-2017

The Luxembourg Institute of Health (LIH) and the renowned German Cancer Research Centre (DKFZ) have inaugurated a new binational research unit named LOVIT - „Laboratory of Oncolytic Virus Immuno-Therapeutics" - in the presence of the directors of the two institutes.
Read more

All news

Meet us

Upcoming events

30 May 2017

LuxCLIN Conference

Luxembourg (LU)

The LuxCLIN conference will gather experts and opinion leaders who will address the challenges and opportunities of next generation clinical trials. Read more

01 June 2017

Integrating immune and molecular classifications of cancers to guide immunotherapies

Luxembourg (Luxembourg)

Prof Wolf-Hervé FRIDMAN is Professor Emeritus of Immunology at the University of Paris - Descartes, President Canceropole lle de France. Read more

04 October 2017

Impact of big data analytics on Healthcare

Esch-sur-Alzette (LU)

The conference will gather experts and opinion leaders who will address the challenges and opportunities of harnessing the power of big data. Read more

All events

Others clusters in Luxembourg

Menu
Fermer